冠状动脉旁路移植同期行心脏瓣膜置 换术对冠心病合并心脏瓣膜病效果

Effect of Coronary Artery Bypass Transplantation Concurrent with Heart Valve Replacement in the Treatment of Coronary Heart Disease with Heart Valve Disease

摘要:

〔摘 要〕 目的：探讨冠状动脉旁路移植同期行心脏瓣膜置换术治疗冠心病合并心脏瓣膜病效果。 方法：选取南阳市中 心医院2021年1月至2021年12月收治的100例冠心病并心脏瓣膜病患者，采用随机数字表法分为对照组和观察组，各50例。 对照组采用冠状动脉旁路移植非同期行心脏瓣膜置换术治疗，观察组采用冠状动脉旁路移植同期行心脏瓣膜置换术治疗。 结果：观察组患者的手术疗效率高于对照组，差异具有统计学意义（P ＜ 0.05）；观察组患者术后的呼吸机应用时间、住 重症监护室（ICU）时间以及住院时间均短于对照组，差异具有统计学意义（P ＜ 0.05）；术后 3 个月，观察组患者左心 室射血分数（LVEF）高于对照组，左心室舒张末期内径（LVEDD）低于对照组，差异具有统计学意义（P ＜ 0.05）；术后 3 个月，观察组患者缺血持续时间短于对照组，缺血发生次数少对照组，差异具有统计学意义（P ＜ 0.05）；术后观察组 患者的并发症发生率低于对照组，差异具有统计学意义（P ＜ 0.05）。 结论：冠状动脉旁路移植同期行心脏瓣膜置换术 治疗可以降低手术风险，提高治疗效果，促进冠心病并心脏瓣膜病患者术后恢复，改善心功能，减少缺血情况及术后并发 症的发生。

Abstract:

〔Abstract〕 Objective To investigate the effect of coronary artery bypass transplantation concurrent with heart valve replacement in the treatment of coronary heart disease with heart valve disease. Methods 100 patients with coronary heart disease and valvular heart disease admitted to Nanyang Central Hospital from January 2021 to December 2021 were randomly divided into a control group and an observation group, with 50 patients in each group. The control group was treated with coronary artery bypass transplantation and heart valve replacement surgery not the same time, while the observation group was treated with coronary artery bypass transplantation and heart valve replacement surgery at the same time. Results The surgical treatment efficiency of the observation group was higher than that of the control group, and the difference was statistically significant (P < 0.05); The observation group had shorter postoperative ventilator application time, intensive care unit (ICU) stay time, and hospitalization time compared to the control group, with statistically significant differences (P < 0.05); Three months after operation, the left ventricular ejection fraction (LVEF) in the observation group was higher than that of the control group, and the left ventricular end diastolic diameter (LVEDD) was lower than that of the control group, with a statistically significant difference (P < 0.05); Three months after surgery, the duration of ischemia in the observation group was shorter than that of the control group, and the number of ischemic occurrences was lower than that of the control group, with a statistically significant difference (P < 0.05); The postoperative incidence of complications in the observation group was lower than that of the control group, and the difference was statistically significant (P < 0.05). Conclusion Coronary artery bypass transplantation concurrent with heart valve replacement can reduce the risk of operation, improve the therapeutic effect, promote the postoperative recovery of patients with coronary heart disease and valvular heart disease, improve cardiac function, and reduce ischemia and postoperative complications.